Potential Myocardial Iron Content Evaluation by Magnetic Resonance Imaging in Thalassemia Major Patients Treated with Deferoxamine or Deferiprone During a Randomized Multicenter Prospective Clinical Study

References

• Oliveri N. F., Nathan D. G., MacMillan J. H., Wayne A. S., Liu P. P., McGee A., Martin M., Koren G., Cohen A. R. Survival in medically treated patients with homozygous β‐thalassemia. N Engl J Med 1994; 331: 574–578
   PubMed Web of Science ®Google Scholar
• Brittenham G. M., Griffith P. M., Nienhuis A. W., McLaren C. E., Young N. S., Tucker E. E., Allen C. J., Farrell D. E., Harris J. W. Efficacy of deferoxamine in preventing complications of iron overload in patients with thalassemia major. N Engl J Med 1994; 331: 567–573
   PubMed Web of Science ®Google Scholar
• Jacobs A. The pathology of iron overload. Iron in Biochemistry and Medicine, II, A. Jacobs, M. Worwood. Academic Press, New York 1980; 439–452
   Google Scholar
• Fosburg M. T., Nathan D. G. Treatment of Cooley's anemia. Blood 1990; 76: 435–444
   PubMed Web of Science ®Google Scholar
• Orton R., Veber L., Sulh I. I. Ocular and auditory toxicity of high dose subcutaneous deferoxamine therapy. Can J Ophthalmol 1985; 20: 153–156
   PubMed Web of Science ®Google Scholar
• Piga A., Luzzato L., Capalbo P., Gambotto S., Tricta F., Gabutti V. High‐dose deferoxamine as a cause of growth failure in thalassaemic patients. Eur J Haematol 1988; 40: 380–381
   PubMed Web of Science ®Google Scholar
• Koren G., Kochavi‐Atiya Y., Bentur Y., Olivieri N. F. The effects of subcutaneous deferoxamine administration on renal function in thalassemia major. Int J Haematol 1992; 54: 371–374
   Google Scholar
• Tenenbein M., Kowalsky S., Sienko A., Bowden D. H., Adamson I. Y.R. Pulmonary toxic effects of continuous deferoxamine administration in acute iron poisoning. The Lancet 1992; 339: 669–704
   PubMedGoogle Scholar
• Hoffbrand A. V., Wonke B. Iron chelation therapy. J Int Med 1997; 242: 37–41
   Google Scholar
• Maggio A., D'Amico G., Morabito A., Capra M., Ciaccio C., Cianciulli P., Di Gregorio F., Garozzo G., Malizia R., Magnano C., Mangiagli A., Quarta G., Rizzo M., D'Ascola G. D., Rizzo A., Midiri M. Deferiprone versus Deferoxamine in patients with thalassemia major: a randomized clinical trial. Blood Cells Mol Dis 2002; 28: 196–208
   PubMed Web of Science ®Google Scholar
• Crosby W. H. Serum ferritin fails to indicate hemochromatosis: nothing gold can stay. N Engl J Med 1976; 294: 333–334
   PubMedGoogle Scholar
• Green R., Watson L. R., Saab G. A., Crosby W. H. Normal serum ferritin: a caution. Blood 1977; 50: 545–547
   PubMed Web of Science ®Google Scholar
• Overmoyer B. A., McLaren C. E., Brittenham G. M. Uniformity of liver density and non haem (storage) iron distribution. Arch Pathol Lab Med 1987; 11: 549–554
   Google Scholar
• Ludwig J., Batts K. P., Moyer T. P., Baldus W. P., Fairbanks V. F. Liver biopsy diagnosis of homozygous hemochromatosis: a diagnostic algorithm. Mayo Clin Proc 1993; 68: 263–267
   PubMedGoogle Scholar
• Boucher E., Bourienne A., Adams P., Turlin B., Brissot P., Deugnier Y. Liver iron concentration and distribution in chronic hepatitis C before and after interferon treatment. Gut 1997; 41: 115–120
   PubMedGoogle Scholar
• Turlin B., Deugnier Y. Evaluation and interpretation of iron in the liver. Semin Diagn Pathol 1998; 15: 237–245
   PubMed Web of Science ®Google Scholar
• Gomori J. M., Horev G., Tamary H., Zandback J., Kornreich L., Zaizov R., Freud E., Krief O., Ben‐Meier J., Rotem H. Hepatic iron overload: quantitative MR imaging. Radiology 1991; 179: 367–369
   PubMed Web of Science ®Google Scholar
• Gandon Y., Guyader D., Heautot J. F., Reda M. I., Yaouanq J., Buhe T., Brissot P., Carsin M., Deugnier Y. Haemochromatosis: diagnosis and quantification of liver iron with gradient‐echo MR imaging. Radiology 1994; 193: 533–538
   PubMed Web of Science ®Google Scholar
• Jensen P. D., Jensen F. T., Christensen T., Ellegaard J. Non‐invasive assessment of tissue iron overload in the liver by magnetic resonance imaging. Br J Haematol 1994; 87: 171–184
   PubMedGoogle Scholar
• Jensen P. D., Jensen F. T., Christensen T., Ellegaard J. Evaluation of transfusional iron overload before and during iron chelation by magnetic resonance imaging of the liver and determination of serum ferritin in adult non‐thalassaemic patients. Br J Haematol 1995; 89: 880–889
   PubMedGoogle Scholar
• Siegelman E. S., Mitchell D. G., Semelka R. Abdominal iron deposition: metabolism, MR findings, and clinical importance. Radiology 1996; 199: 13–22
   PubMed Web of Science ®Google Scholar
• Johnston D. L., Rice L., Vick G. W., Hedrick T. D., Rokey R. Assessment of tissue iron overload by nuclear magnetic resonance imaging. Am J Med 1989; 87: 40–47
   PubMed Web of Science ®Google Scholar
• Midiri M., Gallo C., Finazzo M., Maggio A., Morabito A., Castelli F., Lagalla R. The liver in patients with β‐thalassemia major. Determination of iron concentration with magnetic resonance imaging. Radiol Med 1999; 97: 60–65
   PubMedGoogle Scholar
• Stark D. D., Moseley M. E., Bacon M. R., Moss A. A., Goldberg H. I., Bass N. M., James T. L. Magnetic resonance imaging and spectroscopy of hepatic iron overload. Radiology 1985; 154: 137–142
   PubMed Web of Science ®Google Scholar
• Midiri M., Lo Casto A., Sparacia G. V., Malizia R., D'Angelo P., De Maria M., Lagalla R. MR imaging of pancreatic changes in patients with transfusion dependent β‐thalassemia major. Am J Radiol 1999; 173: 187–192
   Google Scholar
• Siegelman E. S., Mitchell D. G., Rubin R., Hann H. W., Kaplan K. R., Steiner R. M., Rao V. M., Schuster S. J., Burk D. L., Jr, Rifkin M. D. Parenchymal versus reticuloendothelial iron overload in the liver: distinction with MR imaging. Radiology 1991; 179: 361–366
   PubMed Web of Science ®Google Scholar
• Sparacia G., Midiri M., D'Angelo P., Lagalla R. Magnetic resonance imaging of the pituitary gland in patients with secondary hypogonadism due to transfusional hemochromatosis. MAGMA 1999; 8: 87–90
   PubMedGoogle Scholar
• Argyropoulou M. I., Metafratzi Z., Kiortsis D. N., Bitsis S., Tsatsoulis A., Efremidis S. T2 relaxation rate as an index of pituitary iron overload in patients with β‐thalassemia major. Am J Radiol 2000; 175: 1567–1569
   Google Scholar
• Liu P., Henkelman M., Joshi J., Hardy P., Butany J., Iwanochko M., Clauberg M., Dhar M., Mai D., Waien S., Olivieri N. F. Quantification of cardiac and tissue iron by nuclear magnetic resonance in a novel murine thalassemia‐cardiac iron overload model. Can J Cardiol 1996; 19: 155–164
   Google Scholar
• Mavrogeni S. I., Maris T., Gouliamos A., Vlahos L., Kremastinos D. T. Myocardial iron deposition in β‐thalassemia studied by magnetic resonance imaging. Int J Cardiac Imag 1998; 14: 117–122
   PubMed Web of Science ®Google Scholar
• Jensen P. D., Jensen F. T., Christensen T., Heickendorff L., Jensen L. G., Ellegaard J. Indirect evidence for the potential ability of magnetic resonance imaging to evaluate the myocardial iron content in patients with transfusional iron overload. MAGMA 2001; 12: 153–166
   PubMedGoogle Scholar
• Zaino E. C., Wielopolski L. In vivo measurement of hepatic and cardiac iron in Cooley's anemia by nuclear resonance scattering. Ann NY Acad Sci 1990; 612: 573–576
   Google Scholar
• Anderson L. J., Holden S., Davis B., Prescott E., Charrier C. C., Bunce N. H., Firmin D. N., Wonke B., Porter J., Walker J. M., Pennel D. J. Cardiovascular T2‐star (T2*) magnetic resonance for the early diagnosis of myocardial iron overload. Europ Heart J 2001; 22: 2171–2179
   PubMed Web of Science ®Google Scholar
• Anderson L. J., Wonke B., Prescott E., Holden S., Walker J. M., Pennel D. J. Comparison of effects of oral deferiprone and subcutaneous deferoxamine on myocardial iron concentration and ventricular function in β‐thalassaemia. The Lancet 2002; 360: 516–520
   PubMed Web of Science ®Google Scholar
• Richard P. J. King's endomyocardial bioptame. The Lancet 1974; ii: 660
   Google Scholar
• Gomori J. M., Grossman R. I., Drott H. R. MR relaxation times and iron content of thalassemic spleens: an in vitro study. Am J Radiol 1988; 150: 567–569
   Google Scholar
• Kaltwasser J. P., Gottsschalk R., Schalk K. P., Hartl W. Non‐invasive quantitation of liver iron overload by magnetic resonance imaging. Br J Haematol 1990; 74: 360–363
   PubMed Web of Science ®Google Scholar
• Rocchi E., Cassanelli M., Borghi A., Paolillo F., Pradelli M., Casalgrandi G., Burani A., Gallo E. Magnetic resonance imaging and different levels of iron overload in chronic liver disease. Hepatology 1993; 17: 997–1002
   PubMedGoogle Scholar
• Barosi G., Arbustini E., Gavazzi A., Grasso M., Pucci A. Myocardial iron grading by endomyocardial biopsy. A clinico‐pathologic study on iron overloaded patients. Eur J Haematol 1989; 42: 382–388
   PubMed Web of Science ®Google Scholar